Budesonide+Salmeterol DPI - 240/20µg or 120/20µg FDC

Budesonide+Salmeterol DPI - 240/20µg or 120/20µg FDC
Product Description

Intro

Dossier:
Indication:
Formulation:


 Innovative Fixed Dose Combination of Budesonide and Salmeterol at in two dosages : 240/20µg and 120/20µg (delivered dose) as dry powder for inhalation.Dossier : CTD
Indication: Regular treatment of asthma where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate Symptomatic treatment of patients with severe COPD (planned).
Formulation : Dry inhalation powder in hard capsules + specific and patented device.

SMB Laboratories SA

  • BE
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator
Specifications

SMB Laboratories SA

  • BE
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator

More Products from SMB Laboratories SA (4)